Loading…
Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis
Suspending bisphosphonates (BPs) to reduce the risk and severity of medication-related osteonecrosis of the jaw (MRONJ) remains controversial. In this study, we quantitatively evaluated the clinical significance of BP suspension before surgery in osteoporosis patients with MRONJ. We analyzed 24 oste...
Saved in:
| Published in: | Journal of the Korean Association of Oral and Maxillofacial Surgeons 2023, 49(2), , pp.75-85 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c441t-3a4ce0cc6670341fca1109ed365615a6e91d7a07d9fb5d34e67665c345b767f53 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c441t-3a4ce0cc6670341fca1109ed365615a6e91d7a07d9fb5d34e67665c345b767f53 |
| container_end_page | 85 |
| container_issue | 2 |
| container_start_page | 75 |
| container_title | Journal of the Korean Association of Oral and Maxillofacial Surgeons |
| container_volume | 49 |
| creator | Mustakim, Kezia Rachellea Eo, Mi Young Lee, Ju Young Seo, Mi Hyun Kim, Soung Min |
| description | Suspending bisphosphonates (BPs) to reduce the risk and severity of medication-related osteonecrosis of the jaw (MRONJ) remains controversial. In this study, we quantitatively evaluated the clinical significance of BP suspension before surgery in osteoporosis patients with MRONJ.
We analyzed 24 osteoporosis patients with MRONJ who were treated from 2012 to 2020 at Seoul National University Dental Hospital and compared the treatment outcomes of those who suspended BPs with those who did not. The number of surgical interventions, follow-up panoramic radiographs for relative bone density measurement, and laboratory blood tests including white blood cells, erythrocyte sedimentation rate, absolute neutrophil count, hemoglobin, hematocrit, and alkaline phosphatase were analyzed. ANOVA, Student's t -test, and Mann-Whitney U tests were used to compare results. Fisher's exact test was used to discover the association between treatment outcome and BP suspension, and Pearson's correlation test was used to measure the statistical relationship between the changes in serum inflammatory markers.
The number of interventions was significantly higher in the non-drug suspension group due to recurrence ( |
| doi_str_mv | 10.5125/jkaoms.2023.49.2.75 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10218322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2807911301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-3a4ce0cc6670341fca1109ed365615a6e91d7a07d9fb5d34e67665c345b767f53</originalsourceid><addsrcrecordid>eNpVUV1rGzEQFKWlCW5-QaHosRTuqm_lnkowbRIIFEr6LGTdni37LLmSnNB_X53PDa0Q7IqdmV3tIPSeklZSJj9vdzbuc8sI463oWtZq-QpdMsZFIztOXp9zLSW5QFc5b0k9immu2Vt0wTWlQgh5icpy9ME7O-Ls18EPNQ0OcBxwn45r7CBnW3wMuN499LU8vZoEoy3Q45gLxAAuxezzxCobwFv7jH3AhwqFUDJ-9mUzIw_xBHyH3gx2zHB1jgv089vXx-Vd8_D99n5589A4IWhpuBUOiHNKacIFHZyllHTQcyUVlVZBR3ttie67YSV7LkBppaTjQq600oPkC_Rp1g1pMDvnTbT-FNfR7JK5-fF4byhh9JrXZS3Qlxl8OK7qT10dPdnRHJLf2_T7RP2_EvymCj1VBSqp6qZ2H88KKf46Qi5m77ODcbQB4jEbdk10RykntEL5DJ02lxMML30oMZPBZjbYTAYb0Rlm9NTgw78jvnD-2sn_AMfppVs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2807911301</pqid></control><display><type>article</type><title>Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis</title><source>PubMed Central</source><creator>Mustakim, Kezia Rachellea ; Eo, Mi Young ; Lee, Ju Young ; Seo, Mi Hyun ; Kim, Soung Min</creator><creatorcontrib>Mustakim, Kezia Rachellea ; Eo, Mi Young ; Lee, Ju Young ; Seo, Mi Hyun ; Kim, Soung Min</creatorcontrib><description>Suspending bisphosphonates (BPs) to reduce the risk and severity of medication-related osteonecrosis of the jaw (MRONJ) remains controversial. In this study, we quantitatively evaluated the clinical significance of BP suspension before surgery in osteoporosis patients with MRONJ.
We analyzed 24 osteoporosis patients with MRONJ who were treated from 2012 to 2020 at Seoul National University Dental Hospital and compared the treatment outcomes of those who suspended BPs with those who did not. The number of surgical interventions, follow-up panoramic radiographs for relative bone density measurement, and laboratory blood tests including white blood cells, erythrocyte sedimentation rate, absolute neutrophil count, hemoglobin, hematocrit, and alkaline phosphatase were analyzed. ANOVA, Student's t -test, and Mann-Whitney U tests were used to compare results. Fisher's exact test was used to discover the association between treatment outcome and BP suspension, and Pearson's correlation test was used to measure the statistical relationship between the changes in serum inflammatory markers.
The number of interventions was significantly higher in the non-drug suspension group due to recurrence (
<0.05). The relative bone density in patients who suspended BPs was significantly different over time (
<0.05), with the highest density at one-year follow-up. Fisher's exact test shows an association between successful treatment outcomes and BP suspension. The alkaline phosphatase and erythrocyte sedimentation rate levels decreased significantly in the BP-suspended group, and a positive correlation was found between these elevated markers.
A significant increase in bone density throughout follow-up and a lower number of interventions were found in the BP suspension group compared to the non-drug suspension group. Also, BP suspension decreased inflammatory markers in the serum after surgery, resulting in good treatment outcomes. BP suspension is a prognostic factor for MRONJ and should be implemented before surgery.</description><identifier>ISSN: 2234-7550</identifier><identifier>EISSN: 2234-5930</identifier><identifier>DOI: 10.5125/jkaoms.2023.49.2.75</identifier><identifier>PMID: 37114445</identifier><language>eng</language><publisher>Korea (South): The Korean Association of Oral and Maxillofacial Surgeons</publisher><subject>Original ; 치의학</subject><ispartof>대한구강악안면외과학회지, 2023, 49(2), , pp.75-85</ispartof><rights>Copyright © 2023 The Korean Association of Oral and Maxillofacial Surgeons. All rights reserved. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-3a4ce0cc6670341fca1109ed365615a6e91d7a07d9fb5d34e67665c345b767f53</citedby><cites>FETCH-LOGICAL-c441t-3a4ce0cc6670341fca1109ed365615a6e91d7a07d9fb5d34e67665c345b767f53</cites><orcidid>0000-0001-5285-767X ; 0000-0001-7055-9924 ; 0000-0001-8220-6480 ; 0000-0002-4283-499X ; 0000-0002-6916-0489</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151695/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151695/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37114445$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002952897$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Mustakim, Kezia Rachellea</creatorcontrib><creatorcontrib>Eo, Mi Young</creatorcontrib><creatorcontrib>Lee, Ju Young</creatorcontrib><creatorcontrib>Seo, Mi Hyun</creatorcontrib><creatorcontrib>Kim, Soung Min</creatorcontrib><title>Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis</title><title>Journal of the Korean Association of Oral and Maxillofacial Surgeons</title><addtitle>J Korean Assoc Oral Maxillofac Surg</addtitle><description>Suspending bisphosphonates (BPs) to reduce the risk and severity of medication-related osteonecrosis of the jaw (MRONJ) remains controversial. In this study, we quantitatively evaluated the clinical significance of BP suspension before surgery in osteoporosis patients with MRONJ.
We analyzed 24 osteoporosis patients with MRONJ who were treated from 2012 to 2020 at Seoul National University Dental Hospital and compared the treatment outcomes of those who suspended BPs with those who did not. The number of surgical interventions, follow-up panoramic radiographs for relative bone density measurement, and laboratory blood tests including white blood cells, erythrocyte sedimentation rate, absolute neutrophil count, hemoglobin, hematocrit, and alkaline phosphatase were analyzed. ANOVA, Student's t -test, and Mann-Whitney U tests were used to compare results. Fisher's exact test was used to discover the association between treatment outcome and BP suspension, and Pearson's correlation test was used to measure the statistical relationship between the changes in serum inflammatory markers.
The number of interventions was significantly higher in the non-drug suspension group due to recurrence (
<0.05). The relative bone density in patients who suspended BPs was significantly different over time (
<0.05), with the highest density at one-year follow-up. Fisher's exact test shows an association between successful treatment outcomes and BP suspension. The alkaline phosphatase and erythrocyte sedimentation rate levels decreased significantly in the BP-suspended group, and a positive correlation was found between these elevated markers.
A significant increase in bone density throughout follow-up and a lower number of interventions were found in the BP suspension group compared to the non-drug suspension group. Also, BP suspension decreased inflammatory markers in the serum after surgery, resulting in good treatment outcomes. BP suspension is a prognostic factor for MRONJ and should be implemented before surgery.</description><subject>Original</subject><subject>치의학</subject><issn>2234-7550</issn><issn>2234-5930</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVUV1rGzEQFKWlCW5-QaHosRTuqm_lnkowbRIIFEr6LGTdni37LLmSnNB_X53PDa0Q7IqdmV3tIPSeklZSJj9vdzbuc8sI463oWtZq-QpdMsZFIztOXp9zLSW5QFc5b0k9immu2Vt0wTWlQgh5icpy9ME7O-Ls18EPNQ0OcBxwn45r7CBnW3wMuN499LU8vZoEoy3Q45gLxAAuxezzxCobwFv7jH3AhwqFUDJ-9mUzIw_xBHyH3gx2zHB1jgv089vXx-Vd8_D99n5589A4IWhpuBUOiHNKacIFHZyllHTQcyUVlVZBR3ttie67YSV7LkBppaTjQq600oPkC_Rp1g1pMDvnTbT-FNfR7JK5-fF4byhh9JrXZS3Qlxl8OK7qT10dPdnRHJLf2_T7RP2_EvymCj1VBSqp6qZ2H88KKf46Qi5m77ODcbQB4jEbdk10RykntEL5DJ02lxMML30oMZPBZjbYTAYb0Rlm9NTgw78jvnD-2sn_AMfppVs</recordid><startdate>20230430</startdate><enddate>20230430</enddate><creator>Mustakim, Kezia Rachellea</creator><creator>Eo, Mi Young</creator><creator>Lee, Ju Young</creator><creator>Seo, Mi Hyun</creator><creator>Kim, Soung Min</creator><general>The Korean Association of Oral and Maxillofacial Surgeons</general><general>대한구강악안면외과학회</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope><orcidid>https://orcid.org/0000-0001-5285-767X</orcidid><orcidid>https://orcid.org/0000-0001-7055-9924</orcidid><orcidid>https://orcid.org/0000-0001-8220-6480</orcidid><orcidid>https://orcid.org/0000-0002-4283-499X</orcidid><orcidid>https://orcid.org/0000-0002-6916-0489</orcidid></search><sort><creationdate>20230430</creationdate><title>Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis</title><author>Mustakim, Kezia Rachellea ; Eo, Mi Young ; Lee, Ju Young ; Seo, Mi Hyun ; Kim, Soung Min</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-3a4ce0cc6670341fca1109ed365615a6e91d7a07d9fb5d34e67665c345b767f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Original</topic><topic>치의학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mustakim, Kezia Rachellea</creatorcontrib><creatorcontrib>Eo, Mi Young</creatorcontrib><creatorcontrib>Lee, Ju Young</creatorcontrib><creatorcontrib>Seo, Mi Hyun</creatorcontrib><creatorcontrib>Kim, Soung Min</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Journal of the Korean Association of Oral and Maxillofacial Surgeons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mustakim, Kezia Rachellea</au><au>Eo, Mi Young</au><au>Lee, Ju Young</au><au>Seo, Mi Hyun</au><au>Kim, Soung Min</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis</atitle><jtitle>Journal of the Korean Association of Oral and Maxillofacial Surgeons</jtitle><addtitle>J Korean Assoc Oral Maxillofac Surg</addtitle><date>2023-04-30</date><risdate>2023</risdate><volume>49</volume><issue>2</issue><spage>75</spage><epage>85</epage><pages>75-85</pages><issn>2234-7550</issn><eissn>2234-5930</eissn><abstract>Suspending bisphosphonates (BPs) to reduce the risk and severity of medication-related osteonecrosis of the jaw (MRONJ) remains controversial. In this study, we quantitatively evaluated the clinical significance of BP suspension before surgery in osteoporosis patients with MRONJ.
We analyzed 24 osteoporosis patients with MRONJ who were treated from 2012 to 2020 at Seoul National University Dental Hospital and compared the treatment outcomes of those who suspended BPs with those who did not. The number of surgical interventions, follow-up panoramic radiographs for relative bone density measurement, and laboratory blood tests including white blood cells, erythrocyte sedimentation rate, absolute neutrophil count, hemoglobin, hematocrit, and alkaline phosphatase were analyzed. ANOVA, Student's t -test, and Mann-Whitney U tests were used to compare results. Fisher's exact test was used to discover the association between treatment outcome and BP suspension, and Pearson's correlation test was used to measure the statistical relationship between the changes in serum inflammatory markers.
The number of interventions was significantly higher in the non-drug suspension group due to recurrence (
<0.05). The relative bone density in patients who suspended BPs was significantly different over time (
<0.05), with the highest density at one-year follow-up. Fisher's exact test shows an association between successful treatment outcomes and BP suspension. The alkaline phosphatase and erythrocyte sedimentation rate levels decreased significantly in the BP-suspended group, and a positive correlation was found between these elevated markers.
A significant increase in bone density throughout follow-up and a lower number of interventions were found in the BP suspension group compared to the non-drug suspension group. Also, BP suspension decreased inflammatory markers in the serum after surgery, resulting in good treatment outcomes. BP suspension is a prognostic factor for MRONJ and should be implemented before surgery.</abstract><cop>Korea (South)</cop><pub>The Korean Association of Oral and Maxillofacial Surgeons</pub><pmid>37114445</pmid><doi>10.5125/jkaoms.2023.49.2.75</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-5285-767X</orcidid><orcidid>https://orcid.org/0000-0001-7055-9924</orcidid><orcidid>https://orcid.org/0000-0001-8220-6480</orcidid><orcidid>https://orcid.org/0000-0002-4283-499X</orcidid><orcidid>https://orcid.org/0000-0002-6916-0489</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2234-7550 |
| ispartof | 대한구강악안면외과학회지, 2023, 49(2), , pp.75-85 |
| issn | 2234-7550 2234-5930 |
| language | eng |
| recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_10218322 |
| source | PubMed Central |
| subjects | Original 치의학 |
| title | Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T19%3A59%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20significance%20of%20drug%20cessation%20on%20medication-related%20osteonecrosis%20of%20the%20jaw%20in%20patients%20with%20osteoporosis&rft.jtitle=Journal%20of%20the%20Korean%20Association%20of%20Oral%20and%20Maxillofacial%20Surgeons&rft.au=Mustakim,%20Kezia%20Rachellea&rft.date=2023-04-30&rft.volume=49&rft.issue=2&rft.spage=75&rft.epage=85&rft.pages=75-85&rft.issn=2234-7550&rft.eissn=2234-5930&rft_id=info:doi/10.5125/jkaoms.2023.49.2.75&rft_dat=%3Cproquest_nrf_k%3E2807911301%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-3a4ce0cc6670341fca1109ed365615a6e91d7a07d9fb5d34e67665c345b767f53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2807911301&rft_id=info:pmid/37114445&rfr_iscdi=true |